Abstract
The aim of this study was to evaluate whether paroxysmal atrial fibrillation (PAF) has an impact on left atrial (LA) function in hypertensive patients and, if so, to select clinical factors influencing this relationship. Sixty-four essential hypertensive patients with PAF (group EHf) and fifty-five patients without PAF (group EH) were enrolled. Using acoustic quantification, the maximal and minimum LA volume (LAVmax, LAVmin), the LA volume at the end of rapid emptying (EREV), and the LA volume at the onset of atrial emptying (OAEV) were measured. The LA total emptying volume (TE; TE = LAVmax − LAVmin), LA rapid emptying volume (RE; RE = LAVmax − EREV), and left atrial ejection fraction (LAEF) = (OAEV − LAVmin)/OAEV × 100% were calculated. LAVmax, LAVmax indexed to body surface area (LAVmaxI), TE and RE were significantly increased in group EHf. LAEF was clearly lower in group EHf than in group EH. The linear regression analysis showed that the frequency and total number of PAF episodes were the factors with the greatest influence on LAVmaxI (r=0.787, p<0.05). TE and frequency of PAF episodes were the most influential factors on RE (r=0.902, p<0.01). These results suggest that the occurrence of PAF in hypertensive patients is associated with enhanced LA reservoir and conduit function and worse booster pump function. The enhancement of LA reservoir function may be related to the frequency and total number of PAF episodes, and the increased LA conduit function may be related to the LA total emptying volume and frequency of PAF episodes.
Similar content being viewed by others
Article PDF
References
Healey JS, Connolly SJ : Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 2003; 91: 9G–14G.
Stefanadis C, Dernellis J, Toutouzas P : A clinical appraisal of left atrial function. Eur Heart J 2001; 22: 22–36.
Dernellis JM, Vyssoulis GP, Zacharoulis AA, Toutouzas PK : Effects of antihypertensive therapy on left atrial function. J Hum Hypertens 1996; 10: 789–794.
Kokubu N, Yuda S, Tsuchihashi K, et al: Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function. Hypertens Res 2007; 30: 13–21.
Bough EW, Gandsman EJ, Shulman RS : Measurement of normal left atrial function with gated radionuclide angiography. Am J Cardiol 1981; 48: 473–478.
Tanabe T, Deguchi Y, Handa S, Takahashi A, Fukushi H : Longer longitudinal atrial dimension in patients with idiopathic paroxysmal atrial fibrillation: a possible cause of atrial fibrillation. Am Heart J 2001; 142: 669–678.
Takahashi N, Imataka K, Seki A, Fujii J : Left atrial enlargement in patients with paroxysmal atrial fibrillation. Jpn Heart J 1982; 23: 677–683.
Spencer KT, Mor-Avi V, Weinert L, Steenhuisen J, Vignon P, Lang RM : Age dependency of left atrial and left ventricular acoustic quantification waveforms for the evaluation of diastolic performance in left ventricular hypertrophy. J Am Soc Echocardiogr 1998; 11: 1027–1035.
Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852–1923.
Masuyama T, Lee JM, Nagano R, et al: Doppler echocardiographic pulmonary venous flow-velocity pattern for assessment of the hemodynamic profile in acute congestive heart failure. Am Heart J 1995; 129: 107–113.
Masugata H, Senda S, Goda F, et al: Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res 2006; 29: 897–903.
Waggoner AD, Miller JG, Perez JE : Two-dimensional echocardiographic automatic boundary detection for evaluation of left ventricular function in unselected adult patients. J Am Soc Echocardiogr 1994; 7: 459–464.
Shibasaki Y, Nishiue T, Masaki H, et al: Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res 2005; 28: 787–795.
Gottdiener JS, Kitzman DW, Aurigemma GP, Arnold AM, Manolio TA : Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study). Am J Cardiol 2006; 97: 83–89.
Erol MK, Yilmaz M, Acikel M, Karakelleoglu S : Left atrial mechanical function in patients with essential hypertension. Acta Cardiol 2002; 57: 323–327.
Nagano R, Masuyama T, Naka M, Hori M, Kamada T : Contribution of atrial reservoir function to ventricular filling in hypertensive patients. Effects of nifedipine administration. Hypertension 1995; 26: 815–819.
Barbier P, Alioto G, Guazzi MD : Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1994; 24: 165–170.
Vaziri SM, Larson MG, Benjamin EJ, Levy D : Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89: 724–730.
Schotten U, Neuberger HR, Allessie MA : The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 2003; 82: 151–162.
Kagawa K, Arakawa M, Miwa H, et al: Left atrial function during left ventricular diastole evaluated by left atrial angiography and left ventriculography. J Cardiol 1994; 24: 317–325.
Qirko S, Tase M, Lushnjari V, Sinjari T : Left atrial contractility function in hypertension. Arch Mal Coeur Vaiss 1996; 89: 1003–1007.
Okazaki H, Minamino T, Tsukamoto O, et al: Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res 2006; 29: 277–284.
Shi Y, Li D, Tardif JC, Nattel S : Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002; 54: 456–461.
Takeuchi K, Ideishi M, Tashiro T, et al: Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers. Hypertens Res 2005; 28: 639–644.
Toutouzas K, Trikas A, Pitsavos C, et al: Echocardiographic features of left atrium in elite male athletes. Am J Cardiol 1996; 78: 1314–1317.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cui, Q., Wang, H., Zhang, W. et al. Enhanced Left Atrial Reservoir, Increased Conduit, and Weakened Booster Pump Function in Hypertensive Patients with Paroxysmal Atrial Fibrillation. Hypertens Res 31, 395–400 (2008). https://doi.org/10.1291/hypres.31.395
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.395
Keywords
This article is cited by
-
Left atrium phasic impairments in paroxysmal atrial fibrillation patients assessed by cardiovascular magnetic resonance feature tracking
Scientific Reports (2022)
-
Early detection of left atrial and bi-ventricular myocardial strain abnormalities by MRI feature tracking in normotensive or hypertensive T2DM patients with preserved LV function
BMC Cardiovascular Disorders (2020)
-
Clinical implication of disturbed left atrial phasic functions in the heterogeneous population associated with hypertension or atrial fibrillation
Cardiovascular Ultrasound (2019)
-
The relationship between blood pressure variability, obesity and left atrial phasic function in hypertensive population
The International Journal of Cardiovascular Imaging (2016)
